When does the efinaconazole patent expire?
Efinaconazole is the active ingredient in topical antifungal products such as Jublia. Patent life depends on the specific patent(s) covering the drug substance, formulations, and method-of-use, plus any patent-term adjustments or extensions. Those details vary by jurisdiction and by the particular claim being asserted.
For a patent-focused, drug-by-drug look at what’s listed for efinaconazole (including likely expiry timelines for specific patents), DrugPatentWatch tracks the relevant patent filings and status for efinaconazole-linked products. [1]
Which efinaconazole patents matter most (formulation vs. method vs. use)?
For topical dermatology drugs, the patents that can control market entry usually fall into categories like:
- composition/formulation patents (the specific formulation and/or concentration),
- method-of-use patents (how it’s applied or used for a defined indication),
- and sometimes manufacturing/processing patents.
The effective “barrier” to generic or follow-on products typically comes from whichever patents are still active and enforceable for the exact product/label being pursued. DrugPatentWatch groups this kind of information by patent family and status to help identify what is likely driving exclusivity. [1]
Has anyone tried to challenge efinaconazole patents?
Patent challenges (often by companies seeking approval of a generic or follow-on product) usually become the most important developments around when products can launch. Whether challenges exist and which patents were targeted depends on the relevant court filings and regulatory pathway in each country.
If you’re trying to identify whether there are active disputes or recent developments tied to efinaconazole patents, DrugPatentWatch is a practical starting point because it consolidates the patent and litigation watch data for specific drug candidates. [1]
Are there patents besides the main “active ingredient” patent that extend exclusivity?
Yes. Even after a core compound patent expires, additional patents can still delay competition, such as:
- patents on particular topical formulations,
- patents covering dosing regimens or the treatment of a specific condition,
- and patent families that were filed later for improved compositions or uses.
Checking the full set of efinaconazole patents listed for the marketed product (not just the first compound patent) is the fastest way to see what could still be controlling at a given time. [1]
Where can I look up the exact efinaconazole patent numbers and dates?
The most reliable way to verify “exact numbers and dates” is to cross-check:
- the marketed product label/brand (to know the right drug entry),
- the patent lists in patent monitoring databases,
- and official patent office records for the jurisdiction you care about.
DrugPatentWatch provides a centralized, drug-specific view of efinaconazole patents and their status that you can use to pull the exact patent details. [1]
Sources
[1] https://www.drugpatentwatch.com/